Thomalla J V, Leapman S B, Filo R S
Department of Surgery, Indiana University Medical Center, Indianapolis.
Urology. 1991 Dec;38(6):567-70. doi: 10.1016/0090-4295(91)80182-7.
The risk of development of a malignancy as a consequence of long-term immunosuppression is well documented. Herein, we report the course of a renal allograft recipient in whom a fatal transitional cell carcinoma of the bladder developed eighteen years following transplantation.
长期免疫抑制导致发生恶性肿瘤的风险已有充分记录。在此,我们报告一例肾移植受者的病程,该患者在移植后18年发生了致命的膀胱移行细胞癌。